News

Search EMA's news announcements

Резултати (3799)

Update on review of valsartan medicines: risk from NDMA remains low, a related substance NDEA also being investigated

13 September 2018

Press releaseHumanMedicinesReferrals

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 September 2018

7 September 2018

NewsHumanPharmacovigilance

Development of medicines for rare diseases

31 August 2018

NewsCorporate

Towards improving the availability of medicines in the EU

29 August 2018

Press releaseCorporate

Fostering medicines for children

28 August 2018

NewsCorporatePaediatrics

European Medicines Agency closed 27 August 2018

23 August 2018

NewsCorporateMedicines

Keeping medicines safe

22 August 2018

NewsCorporate

Update on medicines containing valsartan from Zhejiang Tianyu: company no longer authorised to manufacture valsartan active substance for EU medicines due to presence of NDMA

20 August 2018

Press releaseCorporate

How are new medicines approved by EMA?

15 August 2018

NewsCorporate

Update on review of valsartan medicines due to detection of NDMA: EMA reviewing valsartan produced by another company Zhejiang Tianyu

10 August 2018

Press releaseHumanMedicines